| # | Title | Journal | Year | Citations |
|---|
| 1 | Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post‐Hoc Analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) Trial | Journal of the American Heart Association | 2017 | 51 |
| 2 | Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities | American Heart Journal | 2017 | 35 |
| 3 | Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial | Metabolism: Clinical and Experimental | 2018 | 30 |
| 4 | Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post‐capillary pulmonary hypertension | European Journal of Heart Failure | 2018 | 27 |
| 5 | Current management and treatment of patients with stable coronary artery diseases presenting to cardiologists in different clinical contexts: A prospective, observational, nationwide study | European Journal of Preventive Cardiology | 2018 | 25 |
| 6 | Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registry | International Journal of Cardiology | 2020 | 23 |
| 7 | Impact of Galectin-3 Circulating Levels on Frailty in Elderly Patients with Systolic Heart Failure | Journal of Clinical Medicine | 2020 | 17 |
| 8 | Left atrial strain predicts exercise capacity in heart failure independently of left ventricular ejection fraction | ESC Heart Failure | 2022 | 17 |
| 9 | Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial | Pulmonary Pharmacology and Therapeutics | 2017 | 16 |
| 10 | Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study | European Heart Journal Quality of Care & Clinical Outcomes | 2019 | 14 |
| 11 | Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension | PLoS ONE | 2017 | 13 |
| 12 | Mineralocorticoid receptor antagonists for heart failure: a real‐life observational study | ESC Heart Failure | 2018 | 13 |
| 13 | Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI‐HF trial | ESC Heart Failure | 2020 | 12 |
| 14 | Secondary prevention: Where we are | European Journal of Preventive Cardiology | 2017 | 11 |
| 15 | Prevalence of exertional oscillatory ventilation in continuous-flow left ventricular assist device recipients | European Journal of Preventive Cardiology | 2018 | 8 |
| 16 | Cardiac Magnetic Resonance in Stable Coronary Artery Disease: Added Prognostic Value to Conventional Risk Profiling | BioMed Research International | 2018 | 8 |
| 17 | Characteristics, treatment and quality of life of stable coronary artery disease patients with or without angina: Insights from the START study | PLoS ONE | 2018 | 8 |
| 18 | Pick Your Threshold | Chest | 2022 | 8 |
| 19 | Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease | Clinical Cardiology | 2018 | 7 |
| 20 | Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EORP Atrial Fibrillation Ablation Long-Term and Atrial Fibrillation General Pilot Registries | Europace | 2020 | 7 |
| 21 | Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries | Cardiovascular Therapeutics | 2020 | 7 |
| 22 | Additive Value of Biomarkers and Echocardiography to Stratify the Risk of Death in Heart Failure Patients with Reduced Ejection Fraction | Cardiology Research and Practice | 2019 | 6 |
| 23 | Prognostic relevance of Doppler echocardiographic re-assessment in HFrEF patients | International Journal of Cardiology | 2021 | 5 |
| 24 | Lipid-Lowering Therapy in Patients with Coronary Heart Disease and Prior Stroke: Mission Impossible? | Journal of Clinical Medicine | 2021 | 5 |
| 25 | Heart valve calcification and cardiac hemodynamics | Echocardiography | 2021 | 5 |
| 26 | Evolving determinants of carotid atherosclerosis vulnerability in asymptomatic patients from the MAGNETIC observational study | Scientific Reports | 2021 | 4 |
| 27 | Nonresponse to Acute Vasodilator Challenge and Prognosis in Heart Failure With Pulmonary Hypertension | Journal of Cardiac Failure | 2021 | 4 |
| 28 | Clinical characteristics of heart failure patients undergoing atrial fibrillation ablation today in Europe. Data from the atrial fibrillation registries of the European Society of Cardiology and the European Heart Rhythm Association | European Journal of Heart Failure | 2019 | 3 |
| 29 | Impact of history of depression on 1-year outcomes in patients with chronic coronary syndromes: An analysis of a contemporary, prospective, nationwide registry | International Journal of Cardiology | 2021 | 3 |
| 30 | Impact of serum uric acid levels on cardiovascular events and quality of life in patients with chronic coronary syndromes: Insights from a contemporary, prospective, nationwide registry | Nutrition, Metabolism and Cardiovascular Diseases | 2022 | 3 |
| 31 | Clinical Impact and Prognostic Role of Triglyceride to High-Density Lipoprotein Cholesterol Ratio in Patients With Chronic Coronary Syndromes at Very High Risk: Insights From the START Study | Frontiers in Cardiovascular Medicine | 2022 | 3 |
| 32 | Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes | Diabetes and Metabolism | 2018 | 2 |
| 33 | Brachial pulse pressure in acute heart failure. Results of the Heart Failure Registry | ESC Heart Failure | 2019 | 2 |
| 34 | Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry | International Journal of Cardiology | 2022 | 2 |
| 35 | Impact of eGFR rate on 1-year all-cause mortality in patients with stable coronary artery disease | European Journal of Internal Medicine | 2022 | 2 |
| 36 | Searching for the holy grail of cardiovascular prevention | European Journal of Preventive Cardiology | 2018 | 1 |
| 37 | Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks | JAMA Cardiology | 2018 | 1 |
| 38 | Exertional oscillatory ventilation in patients supported with continuous-flow left ventricular assist device: Not so exceptional as supposed | European Journal of Preventive Cardiology | 2018 | 0 |
| 39 | Indexes of Angiogenic Activation in Myocardial Samples of Patients with Advanced Chronic Heart Failure | Medicina (Lithuania) | 2019 | 0 |
| 40 | Risk scores, atherosclerotic cardiovascular disease and the crystal ball | European Journal of Preventive Cardiology | 2021 | 0 |
| 41 | Comparing the Prognostic Impact of Prediabetes with Diabetes in a Nationwide Cohort of Patients with Chronic Coronary Syndromes: An Analysis of the START Registry | Cardiology | 2021 | 0 |
| 42 | Exercise intensity assessment and prescription in cardiovascular rehabilitation: never ending story | European Journal of Preventive Cardiology | 2021 | 0 |
